S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 83 200 KRW -2.92% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Other Long-Term Assets
â‚©15.7B
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Other Long-Term Assets
â‚©24.8B
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Other Long-Term Assets
â‚©1.7B
CAGR 3-Years
-27%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Other Long-Term Assets
â‚©639.8m
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Other Long-Term Assets
â‚©5.1B
CAGR 3-Years
37%
CAGR 5-Years
17%
CAGR 10-Years
20%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Other Long-Term Assets
â‚©957.6m
CAGR 3-Years
55%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

ST Pharm Co Ltd
Glance View

Market Cap
1.6T KRW
Industry
Life Sciences Tools & Services

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2016-06-23. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The firm's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
97 768.06 KRW
Undervaluation 15%
Intrinsic Value
Price
S

See Also

What is ST Pharm Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
15.7B KRW

Based on the financial report for Sep 30, 2024, ST Pharm Co Ltd's Other Long-Term Assets amounts to 15.7B KRW.

What is ST Pharm Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
9%

Over the last year, the Other Long-Term Assets growth was 18%. The average annual Other Long-Term Assets growth rates for ST Pharm Co Ltd have been 4% over the past three years , 9% over the past five years .

Back to Top